The Indefinite Delivery Contract awarded by the Department of the Air Force Air Combat Command is a single award contract to Biofire Defense LLC for Biofire test kits and reagents. With a potential value of $1.7 million and a period of performance through July 2028, the contract enables the 99th Medical Group to issue delivery orders for diagnostic products over the next five years in support of their biological detection operations.
No set-aside was used for this SBIR Phase III contract action. As the prime contractor, Biofire Defense will provide their Biofire diagnostic platform and consumables to the 99th Medical Group, a unit of the Air Force's Air Combat Command stationed at Nellis Air Force Base. Biofire's easy-to-use molecular diagnostic tests integrate polymerase chain reaction (PCR) and microarray technologies, allowing rapid, automated identification of pathogens directly from clinical samples. This enables the 99th Medical Group to conduct on-site biological detection and receive results within hours to inform response and treatment decisions.
Generated 1/5/24, 1:40 AM